Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rosemurgy

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Surgical Endoscopy|December 6, 2006
BMI affects presenting symptoms of achalasia and outcome after Heller myotomyS S Rakita, D Villadolid, C Kalipersad, et al.
American Journal of Clinical Oncology|June 11, 1999
Marimastat in patients with advanced pancreatic cancer: a dose-finding studyA Rosemurgy, J Harris, A Langleben, et al.
Current Surgery|January 1, 1983
Design and anatomic location of the ileal reservoir determine functional results after ileoanal anastomosisA A Rosemurgy, W H Schraut, C H Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trialS R Bramhall, A Rosemurgy, P D Brown, et al.
The American Surgeon|June 21, 2001
Delay in treatment of biliary disease during pregnancy increases morbidity and can be avoided with safe laparoscopic cholecystectomyJ Muench, M Albrink, F Serafini, et al.
The Journal of Surgical Research|July 18, 2000
Videoscopic Heller myotomy for achalasia--results beyond short-term follow-upM Bloomston, W Boyce, J Mamel, et al.
The Journal of Emergency Medicine|March 1, 1993
System care improves trauma outcome: patient care errors dominate reduced preventable death rateE Thoburn, P Norris, R Flores, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studiesJ Nemunaitis, C Poole, J Primrose, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2006
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter studyD A Richards, K A Boehm, D M Waterhouse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancerT R J Evans, E Van Cutsem, M J Moore, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Surgical Endoscopy|December 6, 2006
BMI affects presenting symptoms of achalasia and outcome after Heller myotomyS S Rakita, D Villadolid, C Kalipersad, et al.
American Journal of Clinical Oncology|June 11, 1999
Marimastat in patients with advanced pancreatic cancer: a dose-finding studyA Rosemurgy, J Harris, A Langleben, et al.
Current Surgery|January 1, 1983
Design and anatomic location of the ileal reservoir determine functional results after ileoanal anastomosisA A Rosemurgy, W H Schraut, C H Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trialS R Bramhall, A Rosemurgy, P D Brown, et al.
The American Surgeon|June 21, 2001
Delay in treatment of biliary disease during pregnancy increases morbidity and can be avoided with safe laparoscopic cholecystectomyJ Muench, M Albrink, F Serafini, et al.
The Journal of Surgical Research|July 18, 2000
Videoscopic Heller myotomy for achalasia--results beyond short-term follow-upM Bloomston, W Boyce, J Mamel, et al.
The Journal of Emergency Medicine|March 1, 1993
System care improves trauma outcome: patient care errors dominate reduced preventable death rateE Thoburn, P Norris, R Flores, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studiesJ Nemunaitis, C Poole, J Primrose, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2006
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter studyD A Richards, K A Boehm, D M Waterhouse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancerT R J Evans, E Van Cutsem, M J Moore, et al.
Pageof 2